Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment
========================================================================================================================================

* Yasuko Tada
* Yosuke Togashi
* Daisuke Kotani
* Takeshi Kuwata
* Eichi Sato
* Akihito Kawazoe
* Toshihiko Doi
* Hisashi Wada
* Hiroyoshi Nishikawa
* Kohei Shitara